The achievements of stimulating the immune system through vaccination have been profound, saving millions from sickness and death. Inovio is advancing breakthroughs to extend this legacy to many of today’s challenging diseases. Our synthetic vaccines are designed to treat as well as prevent illness, aiming to break the body’s tolerance of cancerous cells and protect against diverse, changing strains of infectious diseases.

Inovio is revolutionizing vaccines! NASDAQ: INO

Our Partnerships View All

Inovio’s vaccines and delivery technology have attracted pharma companies, government agencies, universities and foundations.
  • Logo: Merck
  •                 Logo: University of Pennsylvania     
  •              Logo: National Cancer Institute